Agilon Health (AGL) Cash from Financing Activities (2020 - 2026)

Agilon Health (AGL) has 7 years of Cash from Financing Activities data on file, last reported at -$5.1 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 3096.89% year-over-year to -$5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.0 million (down 141.6% YoY) and the FY2025 annual result came in at -$3.0 million, down 15.91% from the prior year.
• Cash from Financing Activities slipped to -$5.1 million in Q1 2026, from -$17000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $13.5 million in Q1 2022 to a low of -$202.0 million in Q2 2023.
• A 5-year average of -$10.3 million and a median of -$22000.0 in 2024 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 916.85% — and 2023, when it tumbled 4788.72%.
• Tracing AGL's Cash from Financing Activities over 5 years: stood at $1.1 million in 2022, then plunged by 174.78% to -$845000.0 in 2023, then surged by 97.4% to -$22000.0 in 2024, then climbed by 22.73% to -$17000.0 in 2025, then tumbled by 30176.47% to -$5.1 million in 2026.
• The last three Cash from Financing Activities figures came in at -$5.1 million (Q1 2026), -$17000.0 (Q4 2025), and -$236000.0 (Q3 2025), per Business Quant data.